Skinbiotherap. Share Price (SBTX)

Boardroom changes???????

Never known it so quiet, hopefully acne study out soon.

It’s ironic that I subscribed to this web site recently and after reading this article and considering opinion on the future of UK stocks (which pension funds have stopped investing in) and the future for Aim (down 50% since 2021) and the near impossibility of funding I have sold up most of my Aim holdings. When the overall direction is overwhelmingly down, it doesn’t make sense to me to continue trading on Aim. That there have only been 10 AIM IPOs so far this year tells me the market is broken. It costs around £200k in RNS etc just to stay on Aim. I’m still holding on SBTX (but not adding) and URAH (main market and recently raised twice at around the SP).

It is not specific to SBTX, but it provides details of the board's predicament. Some people may not appreciate it, but they will!

OPEN SOURCE

https://open.substack.com/pub/smallcompanychampion/p/londons-capital-conundrum?r=398wvs&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

Hello Martinu

I am not well versed in such matters either but the RNS implies a direct relationship between macquarie and the purchasers, I assume they agree a price between them.

'Long term shareholders, including Tyndall Investement Management who have invested in the Company since IPO, have agreed to purchase the shares directly from Macquarie Bank.'